Gastric Cancer

Papers
(The H4-Index of Gastric Cancer is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The putative pleiotropic functions of meprin β in gastric cancer1032
Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer104
Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma66
Digital histopathological images of biopsy predict response to neoadjuvant chemotherapy for locally advanced gastric cancer65
Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis62
Methodological and reporting considerations in real-world anamarin studies of gastric cancer-related cachexia55
Risk prediction model for gastric cancer within 5 years in healthy Korean adults54
Decorin as a key marker of desmoplastic cancer-associated fibroblasts mediating first-line immune checkpoint blockade resistance in metastatic gastric cancer54
DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plu51
Dose–response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis50
An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study41
Predicting chemotherapy responsiveness in gastric cancer through machine learning analysis of genome, immune, and neutrophil signatures40
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma37
Comment on: Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study33
Outcomes after gastrectomy according to the Gastrectomy Complications Consensus Group (GCCG) in the Dutch Upper GI Cancer Audit (DUCA)33
LncRNA expression signature identified using genome-wide transcriptomic profiling to predict lymph node metastasis in patients with stage T1 and T2 gastric cancer33
Minimally invasive versus open completion total gastrectomy for remnant gastric cancer: a nationwide propensity score-matched analysis32
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study32
Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management32
Novel affibody molecules targeting the AXL extracellular structural domain for molecular imaging and targeted therapy of gastric cancer31
Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer30
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape29
Prognostic significance of tertiary lymphoid structures in gastric neuroendocrine carcinoma with association to delta-like ligand 3 and neuroendocrine expressions29
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape29
Serum TFF2 as a more reliable biomarker for gastric cancer and early gastric cancer: a cross-sectional population-based study28
FERMT2 drives anoikis resistance and peritoneal metastasis by enhancing extracellular matrix deposition in gastric cancer28
Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies27
Long-term quality of life, financial toxicity, and decision regret following therapeutic and prophylactic gastrectomy for cancer27
0.10555005073547